Category: Globus Medical
Here's a look at some of the top regulatory stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies
Globus Medical acquires Transplant Technologies of Texas, a provider of bone allografts, biomaterials and soft tissue products, for an unspecified amount.
A Pennsylvania judge bars a former Synthes USA sales rep from selling medical devices made by rival Globus Medical to his former Synthes customers.
Globus Medical reports another strong quarter, with sales and profits up following the company's entry to the robotic surgery market.
Globus Medical (NYSE:GMED) got some Wall Street love after reporting a strong 1st quarter, during which the company notched the acquisition of Excelsius Surgical.
Globus Medical shares are up this morning on preliminary 4th-quarter sales numbers that topped expectations and blew away the sluggish overall spinal implant market.
Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street's expectations and sending share prices up today.
Globus Medical gets into the robotic surgery arena with the acquisition of Excelsius Surgical and its positioning platform for spine and brain procedures.
Johnson & Johnson's Synthes subsidiary wins a round in its lawsuit against a former sales rep who jumped ship for rival Globus Medical, when a Pennsylvania appeals court rules that the lower court mistakenly applied California law in denying a Synthes bid for a preliminary injunction.